ctDNA and MRI study for head and neck cancer
Part of Cancer clinical trials.
This study looks at how well two tests, a blood test (ctDNA) and an MRI scan, can track head and neck cancer during and after standard treatment with radiation and chemotherapy. It aims to improve how treatment response is measured.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have squamous cell carcinoma of the head or neck.
- Your treatment plan must include chemotherapy and radiation therapy together, given with a curative (not palliative) intent.
- You must have an ECOG performance status of 0-2, meaning you are fully active or up and about but not bedridden.
- You must be able to have an MRI scan (no metal implants or other reasons you can't have an MRI).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a combined PET/MR scan to better look at head and neck squamous cell cancer before or during treatment. It may help doctors see where the cancer is and how far it has spread, to support planning for curative radiation treatment.
This study looks at head and neck tumors using molecular and genetic tests. It may help doctors learn more about what drives different tumors and how they might respond to treatment, using biopsy or stored tumor tissue.
This study uses repeat MRI scans to look for imaging “markers” that may help doctors better understand head and neck squamous cell cancer. It may be most relevant if you are planning curative surgery and/or (chemo)radiotherapy and can safely undergo MRI more than once.
This study tests whether delaying radiation therapy can help doctors learn more from MRI scans and immune system changes in patients with head and neck cancer. This could lead to better treatment decisions.
This trial uses a blood test to look for tiny bits of tumor DNA after treatment for head and neck cancer. It aims to see if this test can detect any remaining cancer cells early, so you and your doctor can make informed decisions.
This study looks at whether measuring a DNA fragment in the blood (called ctDNA) can help predict how well radiotherapy works for head and neck cancer. It may help doctors better tailor treatment for patients with stage III or IV disease.
Hear when a new Head and Neck Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.